A carregar...
The long journey to bring a Myc inhibitor to the clinic
The oncogene Myc is deregulated in the majority of human tumors and drives numerous hallmarks of cancer. Despite its indisputable role in cancer development and maintenance, Myc is still undrugged. Developing a clinical inhibitor for Myc has been particularly challenging owing to its intrinsically d...
Na minha lista:
| Publicado no: | J Cell Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Rockefeller University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8240852/ https://ncbi.nlm.nih.gov/pubmed/34160558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1083/jcb.202103090 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|